CN1345586A - Medicine for relieving itching and detumescence - Google Patents
Medicine for relieving itching and detumescence Download PDFInfo
- Publication number
- CN1345586A CN1345586A CN 00130429 CN00130429A CN1345586A CN 1345586 A CN1345586 A CN 1345586A CN 00130429 CN00130429 CN 00130429 CN 00130429 A CN00130429 A CN 00130429A CN 1345586 A CN1345586 A CN 1345586A
- Authority
- CN
- China
- Prior art keywords
- medicine
- antipruritic
- detumescence
- tannic acid
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a medicine providing functions of relieving itching and swelling. The medicine consists of methylene blue and tannic acid. Modsage forms can be made from said two materials. The medicine provides notable curing effect to itching and a fiery sore especially that is caused by bite of mosquito, biting midges and flea.
Description
The present invention relates to a kind of antipruritic, detumescence medicine, a kind of specifically symptoms such as the pruritus that caused, redness that insects such as mosquito, midge, flea are bitten have medicine antipruritic, the detumescence effect.
Behind mosquito, midge, the flea bite human body skin, symptoms such as pruritus, redness can appear in the affected part, have seriously disturbed people's orthobiosis.According to Ministry of Public Health unified editing higher medical universities and colleges' teaching materials " skin cypridology " (third edition, 1996 publish) record, the generation of these symptoms is mainly by 4 kinds of approach: 1, bite mechanical damage in the process.2, the toxicity of the secretions of insect, Excreta, venom etc. stimulates.3, the anaphylactic type that causes of poison gland leachate of insect and antigenic substance that saliva contains.4, the mouthpart of insecticide is left over the foreign body reaction that causes in vivo.Symptoms such as redness, pruritus mainly by the 2nd, the 3rd kind of reason cause.
At present, biting the pruritus, the redness that are caused at mosquito, midge, flea etc. does not still have than good method, and symptom the lighter will not treat substantially, and heavier person can give following a few class Drug therapy:
1. nice and cool class medicine.This class medicine is to be the various kinds of drug that substrate is made with the Mentholum, is used for antipruritic by feeling nice and cool.For example menthocamphorate, essential balm.It is the most extensive that this class clinical drug uses, but antipruritic, the detumescence curative effect is relatively poor.
2. alkalescent medicine.By in and the polypide acid venom of discharging come relief of symptoms.Be mainly the ammonia preparation.Because of it has than penetrating odor and remission are not obvious greatly, now substantially need not.
3. anaesthetize the class medicine.Representing medicine is lignocaine, procaine.This class medicine is anaesthetized teleneuron by modes such as local anaesthesia, sealings, plays itching-relieving action.Its shortcoming is that action time is short, uses inconvenience, and misery is arranged.
4. antihistaminic.This class medicine is gone up H by suppressing histamine and effector lymphocyte
1The combination of receptor, thus the allergy that it causes suppressed, reach antipruritic, detumescence effect.Represent medicine that diphenhydramine, promethazine are arranged.It is bigger in whole body, no specificity, side effect that its shortcoming is a drug effect.Only the critical patient is used.
5. corticosteroid hormone.This class medicine has antiinflammatory, suppresses immunoreation, effects such as antitoxin.Shortcoming is that specificity is low, and side effect is big, is only applicable to the critical patient.
6. Chinese medicine.The traditional Chinese medical science thinks that this kind pruritus, the red and swollen ailment said due to cold or exposure that belongs to invade due to the skin, and the medicines that dispel the wind that adopt give the compound preparation fumigation and wash method that medicines such as Herba Schizonepetae, Radix Saposhnikoviae, Radix Sophorae Flavescentis, the Fructus Kochiae, Folium Artemisiae Argyi, the Radix Stemonae are formed more in the treatment, and its shortcoming is to use inconvenience, weak curative effect.
The object of the present invention is to provide a kind of antipruritic, detumescence effect that has, can play therapeutical effect pruritus, the redness that mosquito, midge, flea etc. bite generation, and rapid-action, easy to use medicine.
Solution of the present invention is based on the understanding of modern medicine to pruritus, red and swollen mechanism of production, the toxicity that is primarily aimed at insect secretions, Excreta, venom etc. stimulates, and the process of the anaphylactic type that causes of the antigenic substance that contains of poison gland leachate and saliva.Become to be grouped into for two kinds by serge blue and tannic acid, by antipruritic, the repercussive effect of approach performance of block nerves tip sensory function and precipitation allergic protein.
The present invention is made by following component dry powder: (consumption is a weight portion)
Serge blue 1-200 part tannic acid 20-200 part
The formula optimization weight proportion scope of preparation medicine of the present invention is:
Serge blue 1-20 part tannic acid 20-100 part
Pharmaceutical formulation optimum weight proportioning of the present invention is:
20 parts of 2 parts of tannic acids of serge blue
Most preferred dosage form of the present invention is for making the mixture of solvent with water.
The dry powder blend of above-mentioned arbitrary component can be obtained this medicine after evenly.Materials such as this medicine is water-soluble, ethanol, glycerol.This medicine can add the solvent of arbitrary umber, directly acts on the part of pruritus, redness.
An important feature of the present invention is a serge blue with after tannic acid mixes, and it is antipruritic, the detumescence effect plays joint action of potentiation, obviously is better than using separately serge blue and tannic acid preparation.Serge blue and tannic acid have certain antipruritic, detumescence effect respectively, but use is wherein a kind of separately, and clinical efficacy is relatively poor, does not reach therapeutic effect, so do not use these two kinds of medicines to come antipruritic, detumescence in clinical substantially.
Medical research confirms that skin has the certain absorption effect, when skin bitten swelling appears and after, permeability strengthens, its Absorption can strengthen 2-6 doubly, is suitable for the affected part topical.
Serge blue is mainly used in cyanide and nitrite poisoning at present as a kind of reductant-oxidant.In recent years studies confirm that serge blue can act on teleneuron, cause the damage of nerve marrow reversibility, scratchiness is temporarily disappeared.Its redox also can destroy antigenic substance, weakens the allergy effect.Tannic acid turns usefulness into by tanning, can precipitating proteins, and react with alkaloid and detoxify.After absorbing the affected part, can make the antigenic substance degeneration, suppress allergy, the astriction that itself has energy vasoconstrictive disappears redness.Serge blue can enter affected part (the swelling position after biting) by skin absorbs rapidly with after tannic acid mixes, and plays significantly antipruritic, detumescence effect.
Another important feature of the present invention is that serge blue and tannic acid chemical property are stable, and the two after mixing chemical reaction does not take place, does not produce novel substance, avirulence.On this basis, can be made into various dosage forms such as mixture, tincture, unguentum.Especially with mixture curative effect the best.This medicine can add essence or some other chemical substance and antipruritic, detumescence effect does not go down.This medicine is under some Reducing agent effect (adding zinc powder as dilute sulfuric acid), and its blueness can temporarily disappear and take off, but does not influence its curative effect.
The 3rd characteristics of the present invention are that serge blue mixes its antipruritic, collaborative reinforcement of detumescence effect of back with tannic acid, and its effect becomes positive correlation with the content of this medicine in various dosage forms.
The present invention shows that through clinical use result following advantage is arranged:
This drug effect time fast, be coated with and put in affected part several seconds to one minute most patients affected part pruritus transference cure on the skin.Red and swollen basic the disappearance leaves no trace in 2-12 hour.
2. this pharmaceutical physicochemistry stable in properties can long-term storage in closed environment.Can stable existence in various solvents.
3. this medicine can add other material, makes new preparation, as long as tannic acid, the composition of serge blue own are not destroyed, it is antipruritic, the detumescence effect is constant substantially.
4. after this Drug therapy, every function of illing skin (comprising the pain sensation, sense of touch, thermo aesthesia) can be recovered in the short period (several days) fully, does not stay any sequela.
5. this pharmaceutical properties is stable, and is safe in utilization, has no side effect.For example blue-black ink promptly is the mixed liquor that contains serge blue and tannic acid.Serge blue and tannic acid extensively are present in each kind of plant, the mineral, are extensive use of no obvious adverse reaction as medicine and food composition (containing tannic acid in the routine Folium Camelliae sinensis) in clinical.Serge blue intravenous injection 500mg is still safe in utilization according to reports.
6. this medicine can be made into various dosage forms, and is clinical easy to use.
Claims (7)
1. one kind has medicine antipruritic, the detumescence effect, it is characterized in that it is the medicament of being made by the following weight proportion raw material.
Serge blue 1-200 part tannic acid 20-200 part
2. according to claim 1 have a medicine antipruritic, the detumescence effect, and wherein the weight proportion of each raw material is:
Serge blue 1-20 part tannic acid 20-100 part
3. according to claim 1 have a medicine antipruritic, the detumescence effect, and wherein the weight proportion of each raw material is:
20 parts of 2 parts of tannic acids of serge blue
4. describedly have a medicine antipruritic, the detumescence effect according to claim 1,2 or 3, it is characterized in that said medicament is a said dosage form on any pharmaceutics.
5. according to claim 4 have a medicine antipruritic, the detumescence effect, it is characterized in that said medicament is mixture, unguentum, tincture.
6. according to claim 1,2 or 3 described medicines, it is characterized by that its raw material contains with serge blue or tannic acid is the plant or the mineral of active ingredient.
7. according to claim 1,2 or 3 described medicines, its thing is levied to containing said medicine and having other compound preparation antipruritic, the detumescence effect.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00130429 CN1183912C (en) | 2000-09-26 | 2000-09-26 | Medicine for relieving itching and detumescence |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00130429 CN1183912C (en) | 2000-09-26 | 2000-09-26 | Medicine for relieving itching and detumescence |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1345586A true CN1345586A (en) | 2002-04-24 |
| CN1183912C CN1183912C (en) | 2005-01-12 |
Family
ID=4594179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 00130429 Expired - Fee Related CN1183912C (en) | 2000-09-26 | 2000-09-26 | Medicine for relieving itching and detumescence |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1183912C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102824359A (en) * | 2011-06-17 | 2012-12-19 | 张廷兴 | Mosquito-toxin-removing liniment |
| CN110840902A (en) * | 2019-12-05 | 2020-02-28 | 河北医科大学 | Application of tannic acid in preparing medicine for inhibiting pruritus |
| CN115633691A (en) * | 2022-10-12 | 2023-01-24 | 大连国际旅行卫生保健中心(大连海关口岸门诊部) | Use of tannic acid as component of mosquito attractant |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5998399B1 (en) * | 2015-09-10 | 2016-09-28 | 株式会社ライラック研究所 | Itching prevention agent |
-
2000
- 2000-09-26 CN CN 00130429 patent/CN1183912C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102824359A (en) * | 2011-06-17 | 2012-12-19 | 张廷兴 | Mosquito-toxin-removing liniment |
| CN110840902A (en) * | 2019-12-05 | 2020-02-28 | 河北医科大学 | Application of tannic acid in preparing medicine for inhibiting pruritus |
| CN115633691A (en) * | 2022-10-12 | 2023-01-24 | 大连国际旅行卫生保健中心(大连海关口岸门诊部) | Use of tannic acid as component of mosquito attractant |
| CN115633691B (en) * | 2022-10-12 | 2024-03-29 | 大连国际旅行卫生保健中心(大连海关口岸门诊部) | Use of tannins as mosquito attractant components |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1183912C (en) | 2005-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69832055T2 (en) | TRANSDERMAL DELIVERY SYSTEM | |
| US5162037A (en) | Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration | |
| Mostofa et al. | Antidiabetic effects of Catharanthus roseus, Azadirachta indica, Allium sativum and glimepride in experimentally diabetic induced rat | |
| US20030157185A1 (en) | Topical treatment of neuropathy | |
| US7871647B1 (en) | Topical treatment of neuropathy | |
| CN1084765A (en) | Stasis eliminating bone joint medicine | |
| CN1183912C (en) | Medicine for relieving itching and detumescence | |
| AU632481B2 (en) | Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration | |
| CN1565462A (en) | Itch relieving detumescent medicine | |
| CN100531781C (en) | Chinese medicine composition for removing wart nevus | |
| CN106880670B (en) | A kind of medicine for treating scabies | |
| CN1047080C (en) | Process for preparing medicine to inhibit skin itch | |
| CN114652708B (en) | Composition for treating deep tissue pain | |
| CN1047079C (en) | Process for preparing tinea medicine | |
| CN107213238A (en) | It is a kind of to treat Chinese medicine of venomous snake bite and preparation method thereof | |
| CN1084748A (en) | Quick results arthritis dressing and manufacture method thereof | |
| CN109091535B (en) | Pharmaceutical composition for treating mosquito bite dermatitis and preparation process and application thereof | |
| CN1163241C (en) | Compound Tournefortia monrana granules preparation and preparation thereof process | |
| CN106074995A (en) | A kind of bactericidal composition for treating female sex organs inflammation and application thereof | |
| CN1077893A (en) | Preparation method of Dantian heart-strengthening plaster | |
| CN105641094A (en) | Composition for treating children dermatitis and preparation method thereof | |
| CN108888645A (en) | A kind of Siberian cocklebur grass pine evaporates oily ointment | |
| CN1047081C (en) | Making method of one-time efficacious tinea manuum medicine and toilet water | |
| JPS6229529A (en) | Manufacture of medicine for disease | |
| EP4058039A1 (en) | Homeopathic topical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050112 Termination date: 20091026 |